Characterization of Poldip2 knockout mice: Avoiding incorrect gene targeting
Authors:
- Bernard LassègueBLBernard Lassègue
- Sandeep KumarSKSandeep Kumar
- Rohan MandavilliRMRohan Mandavilli
- Keke WangKWKeke Wang
- Michelle TsaiMTMichelle Tsai
- Dong-Won KangDKDong-Won Kang
- Catherine DemosCDCatherine Demos
- Marina S. HernandesMHMarina S. Hernandes
- Alejandra San MartínAlejandra San Martín
- W. Robert TaylorWTW. Robert Taylor
- Hanjoong JoHanjoong Jo
- Kathy K. GriendlingKGKathy K. Griendling
Open Access
- 20 December 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (12) , e0247261
Abstract
POLDIP2 is a multifunctional protein whose roles are only partially understood. Our laboratory previously reported physiological studies performed using a mouse gene trap model, which suffered from three limitations: perinatal lethality in homozygotes, constitutivePoldip2inactivation and inadvertent downregulation of the adjacentTmem199gene. To overcome these limitations, we developed a new conditional floxedPoldip2model. The first part of the present study shows that our initial floxed mice were affected by an unexpected mutation, which was not readily detected by Southern blotting and traditional PCR. It consisted of a 305 kb duplication aroundPoldip2with retention of the wild type allele and could be traced back to the original targeted ES cell clone. We offer simple suggestions to rapidly detect similar accidents, which may affect genome editing using both traditional and CRISPR-based methods. In the second part of the present study, correctly targeted floxedPoldip2mice were generated and used to produce a new constitutive knockout line by crossing with a Cre deleter. In contrast to the gene trap model, many homozygous knockout mice were viable, in spite of having no POLDIP2 expression. To further characterize the effects ofPoldip2ablation in the vasculature, RNA-seq and RT-qPCR experiments were performed in constitutive knockout arteries. Results show that POLDIP2 inactivation affects multiple cellular processes and provide new opportunities for future in-depth study of its functions.Keywords
All Related Versions
Funding Information
- NIH National Heart, Lung, and Blood Institute (HL95070)
- NIH National Heart, Lung, and Blood Institute (HL152167)
- NIH National Heart, Lung, and Blood Institute (HL119798)
- NIH National Heart, Lung, and Blood Institute (HL095070)
- NIH National Heart, Lung, and Blood Institute (HL139757)
This publication has 63 references indexed in Scilit:
- REVIGO Summarizes and Visualizes Long Lists of Gene Ontology TermsPLOS ONE, 2011
- NORMA-Gene: A simple and robust method for qPCR normalization based on target gene dataBMC Bioinformatics, 2011
- A Mechanistic Model of PCR for Accurate Quantification of Quantitative PCR DataPLOS ONE, 2010
- A Model of Disturbed Flow-Induced Atherosclerosis in Mouse Carotid Artery by Partial Ligation and a Simple Method of RNA Isolation from Carotid EndotheliumJournal of Visualized Experiments, 2010
- Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiationNature Biotechnology, 2010
- Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progressionBMC Genomics, 2010
- Poldip2, a Novel Regulator of Nox4 and Cytoskeletal Integrity in Vascular Smooth Muscle CellsCirculation Research, 2009
- qpcR: an R package for sigmoidal model selection in quantitative real-time polymerase chain reaction analysisBioinformatics, 2008
- An Unstable Targeted Allele of the Mouse Mitf Gene With a High Somatic and Germline Reversion RateGenetics, 2008
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002